On January 6, 2022, the winners of the “2021 annual peak list of new economy” were officially announced at the AI media night · 2022 new economy trend analysis conference. Hangzhou Tangji Medical Technology Co., Ltd. (hereinafter referred to as “Tangji medical”) successfully won the award of “the most investment value brand in 2021” with its continuous exploration and breakthrough in the field of medical innovation.
It is reported that the selection of the “2021 annual peak list of new economy industries” is organized by the world-renowned third-party data mining and analysis organization iimedia Research (AI media consulting), which aims to commend the enterprises, brands and individuals with outstanding performance, outstanding performance and outstanding influence in the new economy industry, so as to make the industry leaders and innovators stand out. Based on the dimensions of investment value, comprehensive strength, development potential and innovation ability, combined with AI media big data monitoring and analysis system and original data modeling system, a large number of Internet users voted and a comprehensive review by nearly 100 authoritative expert think tanks, which is the verification and affirmation of the achievements of new economy enterprises.
This time, Tangji medical won the award of “the brand with the most investment value in 2021”, which shows that it has been recognized by netizens and authoritative review. It has an advanced business model and huge investment space in the field of Innovation Medical Management Co.Ltd(002173) . In this regard, Tangji medical is well deserved.
Tang Ji medical was founded in August 2016, is a focus on obesity, diabetes, fatty liver and other metabolic diseases new research and development of national high-tech enterprises. After years of development, Tangji medical now has dozens of R & D teams composed of many senior experts with many years of working experience in the medical device industry, and many experts in the fields of digestive endoscopy, endocrinology, medical materials, engineering and so on to participate in clinical project research.
In recent years, with the vigorous promotion of national policies, the speed of technological innovation in the medical industry has been accelerating, and the social situation that people pursue higher quality of health security has also become a catalyst for the prosperity of the innovation situation of the whole industry. With the rapid development of China’s economy, more and more people are troubled by obesity and metabolic diseases. Tangji medical has focused on this, established the grand vision of “exploring new ways to treat metabolic diseases”, invested time and energy in the research and development of innovative technologies, and is committed to opening a new era of endoscopic interventional treatment of metabolic diseases. At present, one of Tangji medical’s core products for metabolic diseases, “gastric bypass stent system”, has entered the national Innovation Medical Management Co.Ltd(002173) device special review procedure, and has carried out registered clinical trials in several top three hospitals in China. At the same time, its R & D of other products in the field of metabolic diseases is also being carried out.
The clear research direction and high-quality product matrix make the enterprise development prospect of Tangji medical more diversified and comprehensive. The winning of the award of “the most investment value brand in 2021” represents the recognition and affirmation of the society on the value and comprehensive strength of Tangji medical enterprise. It is also the embodiment of its own great market competitiveness and development potential, which will further encourage Tangji medical to reach a new level in innovation and development.
(source: Hebei Network Radio and television station)
